Cargando…
Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a les...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864924/ https://www.ncbi.nlm.nih.gov/pubmed/31744540 http://dx.doi.org/10.1186/s13256-019-2285-3 |
_version_ | 1783471988733378560 |
---|---|
author | Sasson, Sarah C. Corbett, Alastair McLachlan, Andrew J. Chen, R. Adelstein, S. A. Riminton, Sean Limaye, Sandhya |
author_facet | Sasson, Sarah C. Corbett, Alastair McLachlan, Andrew J. Chen, R. Adelstein, S. A. Riminton, Sean Limaye, Sandhya |
author_sort | Sasson, Sarah C. |
collection | PubMed |
description | BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a lesser known association of myotonic dystrophy type 1 and the underlying pathogenesis of immunoglobulin G depletion remains unclear. CASE PRESENTATION: Here we report a kindred of two members (a 62-year-old white woman and a 30-year-old white man; mother and son) with myotonic dystrophy type 1-associated hypogammaglobulinemia associated with altered intravenous immunoglobulin elimination kinetics and reduced half-life. There was no history of systemic immunosuppression or renal or gastrointestinal protein loss in either patient, and no underlying case for a secondary immunodeficiency could be found. One patient required fortnightly intravenous immunoglobulin to maintain adequate trough immunoglobulin G levels. CONCLUSIONS: Ongoing study of myotonic dystrophy type 1-associated hypogammaglobulinemia using contemporary tools of genomic medicine may help to further delineate the pathogenesis of this entity. |
format | Online Article Text |
id | pubmed-6864924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68649242019-12-12 Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature Sasson, Sarah C. Corbett, Alastair McLachlan, Andrew J. Chen, R. Adelstein, S. A. Riminton, Sean Limaye, Sandhya J Med Case Rep Case Report BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a lesser known association of myotonic dystrophy type 1 and the underlying pathogenesis of immunoglobulin G depletion remains unclear. CASE PRESENTATION: Here we report a kindred of two members (a 62-year-old white woman and a 30-year-old white man; mother and son) with myotonic dystrophy type 1-associated hypogammaglobulinemia associated with altered intravenous immunoglobulin elimination kinetics and reduced half-life. There was no history of systemic immunosuppression or renal or gastrointestinal protein loss in either patient, and no underlying case for a secondary immunodeficiency could be found. One patient required fortnightly intravenous immunoglobulin to maintain adequate trough immunoglobulin G levels. CONCLUSIONS: Ongoing study of myotonic dystrophy type 1-associated hypogammaglobulinemia using contemporary tools of genomic medicine may help to further delineate the pathogenesis of this entity. BioMed Central 2019-11-20 /pmc/articles/PMC6864924/ /pubmed/31744540 http://dx.doi.org/10.1186/s13256-019-2285-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sasson, Sarah C. Corbett, Alastair McLachlan, Andrew J. Chen, R. Adelstein, S. A. Riminton, Sean Limaye, Sandhya Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title | Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title_full | Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title_fullStr | Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title_full_unstemmed | Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title_short | Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
title_sort | enhanced serum immunoglobulin g clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864924/ https://www.ncbi.nlm.nih.gov/pubmed/31744540 http://dx.doi.org/10.1186/s13256-019-2285-3 |
work_keys_str_mv | AT sassonsarahc enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT corbettalastair enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT mclachlanandrewj enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT chenr enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT adelsteinsa enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT rimintonsean enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature AT limayesandhya enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature |